Publications by authors named "Nataliia Limanska"

Article Synopsis
  • Primary liver cancer (PLC), including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), has a high mortality rate and current treatments are limited with severe side effects, highlighting the need for new therapies.
  • The study investigates the anticancer effects of two Lactobacilli strains (Lp 12 and Lp 355), derived from grapes, and compares them to the well-studied strain (Lc 393) on PLC cell lines, testing them in various forms and combinations with standard chemotherapy.
  • Results indicate that both live suspensions and sonicated extracts of the Lactobacilli strains significantly inhibited PLC cell growth and showed synergistic effects when combined with chemotherapeutics, allowing for lower doses
View Article and Find Full Text PDF

In this study, we investigated compounds of plant and mushroom origin belonging to Traditional Chinese Medicine (TCM) and to Traditional Tibetan Medicine (TTM): a sandy beige mushroom Murr, commonly known as Huaier/TCM as well as Ershiwuwei Songshi Wan and Qiwei Honghua Shusheng Wan, which both belong to TTM. We aimed to study the efficacy of TTM and TCM in hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) . TCM and TTM were tested either as a monotherapy, or in combination with standard therapeutics: sorafenib for HCC treatment and gemcitabine for CCA.

View Article and Find Full Text PDF

Seventy-eight isolates of lactic acid bacteria from Ukraine and Thailand were screened for bacteriocinogenic activity against indicator strain Lactobacillus sakei subsp. sakei JCM 1157. One isolate showed an antagonistic activity of cell-free supernatant eliminated after the treatment with Proteinase K.

View Article and Find Full Text PDF

Unlabelled: There is a great interest in developing novel anti-biofilm materials in order to decrease medical device-associated bacterial infections causing morbidity and high healthcare costs. However, the testing of novel materials is often done using bacterial lab strains that may not exhibit the same phenotype as clinically relevant strains infecting medical devices. Furthermore, no consensus of strain selection exists in the field, making results very difficult to compare between studies.

View Article and Find Full Text PDF